Posted On: 12/01/2015 4:49:16 PM
Post# of 30066
Current disease modifying approaches to treat Parkinson's disease - 2015 Nov 30
http://www.ncbi.nlm.nih.gov/pubmed/26616211
Quote:
Neurotrophic factors are by virtue of their survival promoting activities attract candidates to counteract and possibly halt cell degeneration in PD. In particular, studies employing glial cell line-derived neurotrophic factor (GDNF) and its family member neurturin (NRTN), as well as the recently described cerebral dopamine neurotrophic factor (CDNF) and the mesencephalic astrocyte-derived neurotrophic factor (MANF) have shown positive results in protecting and repairing dopaminergic neurons in various models of PD.
http://www.ncbi.nlm.nih.gov/pubmed/26616211
(0)
(0)
